Integrated Smoking Cessation Treatment for Low Income Community Corrections

Not Applicable

Completed

• Conditions: Smoking Cessation
• Interventions: Behavioral: counseling vs. advice

• Registration Number: NCT01257490
• Lead Sponsor: University of Alabama at Birmingham

Brief Summary

This study recruited cigarette smokers under supervision in community corrections (e.g., probation, parole, drug courts, etc.) in the Birmingham, Alabama area. Smokers received 12 weeks of bupropion treatment and brief physician advice to quit smoking or 12 weeks of bupropion treatment and 4 sessions of intensive counseling around smoking cessation. The study was stratified on race such that equal proportions of African Americans and Caucasians were enrolled in the two study groups. It was hypothesized that smokers receiving intensive counseling will have higher quit rates compared to smokers receiving brief advice to quit.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-10
• Study First Submitted: 2010-10-28
• Study First Submitted QC: 2010-12-08
• Study First Posted: 2010-12-09
• Primary Completion: 2014-03
• Study Completion: 2014-03
• Status Verified: 2017-04
• Last Update Submitted: 2017-04-17
• Last Update Posted: 2017-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 689

Inclusion Criteria

• At least 19 years or older
• Enrolled in criminal justice community supervision (e.g., probation, parole, drug court, community corrections, etc)
• Smoking at least 5 cpd for the past year
• Maintained in an unrestricted environment (e.g., not currently in a correctional facility or treatment facility) living in the Birmingham Area and surrounding communities

Exclusion Criteria

• Pregnant or nursing (all women in this study will be required to use an acceptable form of contraception throughout the administration of the medication)
• Known sensitivity to Zyban or Wellbutrin
• History of seizures
• Current or prior anorexia or bulimia
• Abrupt withdrawal from alcohol or benzodiazepines
• Moderate to severe kidney problems
• Moderate liver problems
• Cognitive impairment such that they cannot provide informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intensive counseling	counseling vs. advice	4 sessions of intensive counseling plus bupropion
Brief Counseling	counseling vs. advice	Brief physician advice to quit plus bupropion

Primary Outcome Measures

Name	Time	Method
smoking cessation	12 Month

Trial Locations

Locations (1)

UAB Substance Abuse; 🇺🇸 Birmingham, Alabama, United States